Ribomic to Extend Joint Research Term by 1 Year with Otsuka for Hematological Disorder, Fibrosis Projects

Ribomic Inc., a biopharmaceutical venture company based in Tokyo, said on December 16 that it has entered into an agreement with Otsuka Pharmaceutical to extend the term of the existing joint research deal with Otsuka Pharmaceutical for the two projects...read more